Fig. 3From: Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infectionEffects of the inactivated COVID-19 vaccine on circulating EOS. The promoting effect of 2 doses or 3 doses of COVID-19 vaccine on circulating EOS in the asymptomatic (Fig. 3A, B and E); The effect of COVID-19 vaccines from different manufacturers (Fig. 3C and D); The role of COVID-19 vaccine on CRP levels (Fig. 3F). Non-vaccine: Not vaccinated; Days (0–90), Days (90–150), 150 days later: Time from the last anti-COVID-19 vaccine dose to the onset of symptomsBack to article page